Morgensztern D, Ready N, Johnson ML, Dowlati A, et al. A Phase I First-in-Human Study of ABBV-011, a Seizure-Related Homolog Protein 6-Targeting Antibody-Drug Conjugate, in Patients With Small Cell Lung Cancer. Clin Cancer Res 2024 Sep 17. doi: 10.1158/1078-0432.CCR-24-1547.
PMID: 39287821